PPIDT00210

Drug Information
NameSibrotuzumab
SequenceNot Available
DrugBank_IDDB06474
Typebiotech
IndicationInvestigated for use/treatment in cancer/tumors (unspecified), colorectal cancer, and lung cancer.

Dosage Forms
Form Route Strength
No dosage records.
Target Information
Role Uniprot_ID Gene_Name Entity_Name Organism Actions Internal link
target Q12884 FAP Prolyl endopeptidase FAP Homo sapiens unknown Link